Identification of a patient with atypical MUTYH-associated polyposis through detection of the KRAS c.34G>T mutation in liver metastasis

Journal of Clinical Oncology

Volumn 31, Issue 9, 2013, Pages

  Buisine, Marie Pierre ^a   Cattan, Stéphane ^b   Wacrenier, Agnès ^b   Leclerc, Julie ^b   Lejeune, Sophie ^b  

^a UNIV LILLE   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BEVACIZUMAB; DNA GLYCOSYLASE MUTY; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; FOLINIC ACID; GENOMIC DNA; IRINOTECAN; K RAS PROTEIN; OXALIPLATIN;

ABDOMINAL PAIN; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SCINTISCANNING; CASE REPORT; CELIOSCOPY; CLINICAL FEATURE; COLON ADENOCARCINOMA; COLONOSCOPY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DNA SEQUENCE; FEMALE; FEVER; GENETIC SCREENING; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER ABSCESS; LIVER BIOPSY; LIVER METASTASIS; MUTATIONAL ANALYSIS; MUTY HOMOLOG ASSOCIATED POLYPOSIS; NUCLEOTIDE SEQUENCE; POLYPOSIS; PRIORITY JOURNAL;

ADENOMATOUS POLYPOSIS COLI; ADULT; DNA GLYCOSYLASES; FEMALE; HUMANS; LIVER NEOPLASMS; MUTATION; PROTO-ONCOGENE PROTEINS; RAS PROTEINS;

EID: 84875970926     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.44.7391     Document Type: Article

References (11)

1. Al-Tassan N, Chmiel NH, Maynard J, et al: Inherited variants of MYH associated with somatic G:C→T:A mutations in colorectal tumors. Nat Genet 30:227-232, 2002
2. Sieber OM, Lipton L, Crabtree M, et al: Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 348:791-799, 2003 (Pubitemid 36245755)
3. Jones S, Emmerson P, Maynard J, et al: Biallelic germline mutations in MYH predispose to multiple colorectal adenoma and somatic G:C→T:A mutations. Hum Mol Genet 11:2961-2967, 2002
4. Lipton L, Halford SE, Johnson V, et al: Carcinogenesis in MYH-associated polyposis follows a distinct genetic pathway. Cancer Res 63:7595-7599, 2003 (Pubitemid 37466679)
5. Nielsen M, Joerink-van de Beld MC, Jones N, et al: Analysis of MUTYH genotypes and colorectal phenotypes in patients with MUTYH-associated polyposis. Gastroenterology 136:471-476, 2009
6. Buecher B, Bonaïti C, Buisine MP, et al: French experts report on MUTYH-associated polyposis (MAP). Fam Cancer 11:321-328, 2012
7. Slupska MM, Baikalov C, Luther WM, et al: Cloning and sequencing a human homolog (hMYH) of the Escherichia coli mutY gene whose function is required for the repair of oxidative DNA damage. J Bacteriol 178:3885-3892, 1996 (Pubitemid 26227206)
8. Gu Y, Lu AL: Differential DNA recognition and glycosylase activity of the native human MutY homolog (hMYH) and recombinant hMYH expressed in bacteria. Nucleic Acids Res 29:2666-2674, 2001 (Pubitemid 32600325)
9. Jones S, Lambert S, Williams GT, et al: Increased frequency of the k-ras G12C mutation in MYH polyposis colorectal adenomas. Br J Cancer 90:1591-1593, 2004 (Pubitemid 38648243)
10. Normanno N, Tejpar S, Morgillo F, et al: Implications for KRAS status and EGFR-targeted therapies in metastatic CRC. Nat Rev Clin Oncol 6:519-527, 2009
11. van Puijenbroek M, Nielsen M, Tops CM, et al: Identification of patients with (atypical) MUTYH-associated polyposis by KRAS2 c.34G > T prescreening followed by MUTYH hotspot analysis in formalin-fixed paraffin-embedded tissue. Clin Cancer Res 14:139-142, 2008 (Pubitemid 351377988)